ライフサイエンスコーパス: noninherited

1 ing fetus must not mount immune responses to noninherited Ags on chimeric maternal cells that reside

2 Bacterial persistence, known as noninherited antibacterial resistance, is a factor contr

3 e function of BRCA1 and the role of BRCA1 in noninherited cancer remain unknown.

4 Noninherited cardiomyopathy also displays varying progre

5 thrombotic risk factors include a variety of noninherited clinical conditions that can predispose an

6 prises an emerging spectrum of inherited and noninherited disorders of the immune system characterize

7 s for the similarities between inherited and noninherited forms of breast cancer, we tested the hypot

8 real-time quantitative PCR assay to detect a noninherited HLA allele in the child.

9 By using an mAb recognizing the maternal noninherited HLA-A2 antigen, we found that autologous ce

10 choriomeningitis virus (LCMV) and secondary (noninherited) HLH in which C57BL/6 mice receive repeated

11 has been recently presented to suggest that noninherited human leukocyte antigens (HLAs) originating

12 The mechanisms underlying tolerance to noninherited maternal Ags (NIMA) are not fully understoo

13 The phenomenon of tolerance to noninherited maternal Ags (NIMA) is poorly understood.

14 e hypothesize that developmental exposure to noninherited maternal Ags (NIMA) results in alloantigen-

15 and, in a mouse model system, used neoR as a noninherited maternal allele marker of maternal cells to

16 aternal compared with paternal transmission, noninherited maternal alleles that may work through mate

17 cells and accumulation of T(reg) cells with noninherited maternal antigen (NIMA) specificity are sim

18 f-origin effects) and nontransmission rates (noninherited maternal antigen [NIMA] effects) in other a

19 nologic effects of developmental exposure to noninherited maternal antigens (NIMAs) are quite variabl

20 Early life exposure to noninherited maternal antigens (NIMAs) may occur via tra

21 cells in offspring may promote tolerance to noninherited maternal antigens (NIMAs).

22 Tolerance to noninherited maternal antigens has provided clinical adv

23 murine model that MMc caused exposure to the noninherited maternal antigens in all offspring, but in

24 erving the beneficial effect of tolerance to noninherited maternal antigens on graft survival.

25 es were investigated for the presence of the noninherited maternal gene DRB4, exclusive to the DR53 h

26 were positive and 132 were negative for the noninherited maternal gene.

27 e units testing positive or negative for the noninherited maternal gene.

28 in transplantation, including the effect of noninherited maternal HLA antigens (NIMA) and double-uni

29 ively less information has been available on noninherited modifiable factors that may have an adverse

30 says to detect and quantify MMc by targeting noninherited, nonshared HLA sequences.

31 The low frequency of MET mutations in noninherited papillary renal carcinomas (PRC) suggests t

32 Cronkhite-Canada Syndrome (CCS) is a rare, noninherited polyposis syndrome affecting 1 in every mil

33 pillary renal carcinomas (PRC) suggests that noninherited PRC may develop by a different mechanism th

34 Previously, noninherited rare mutations were shown to contribute to

35 n Gram-negative bacteria, and other forms of noninherited resistance to vancomycin have been discusse

36 ns and may also have a role in patients with noninherited tumors that have decreased BRCA activity.